Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression-Reference-Cited by-同舟云学术

Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression

Published:2018-10 Issue:10 Volume:24 Page:2040-2046
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Jacobsohn David A.,Loken Michael R.,Fei Mingwei,Adams Alexia,Brodersen Lisa Eidenschink,Logan Brent R.,Ahn Kwang Woo,Shaw Bronwen E.,Kletzel Morris^ORCID,Olszewski Marie,Khan Sana,Meshinchi Soheil,Keating Amy,Harris Andrew,Teira Pierre,Duerst Reggie E.,Margossian Steven P.,Martin Paul L.,Petrovic Aleksandra,Dvorak Christopher C.^ORCID,Nemecek Eneida R.,Boyer Michael W.,Chen Allen R.,Davis Jeffrey H.,Shenoy Shalini,Savasan Sureyya^ORCID,Hudspeth Michelle P.,Adams Roberta H.,Lewis Victor A.,Kheradpour Albert,Kasow Kimberly A.,Gillio Alfred P.,Haight Ann E.,Bhatia Monica,Bambach Barbara J.,Haines Hilary L.,Quigg Troy C.,Greiner Robert J.,Talano Julie-An M.^ORCID,Delgado David C.,Cheerva Alexandra,Gowda Madhu,Ahuja Sanjay,Ozkaynak Mehmet,Mitchell David,Schultz Kirk R.,Fry Terry J.,Loeb David M.,Pulsipher Michael A.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference26 articles.

1. Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia;Kern;Blood,2004

2. The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy;Laane;Haematologica,2006

3. The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia;Buccisano;Leukemia,2006

4. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry;Sievers;J Natl Cancer Inst,1996

5. Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia;Sievers;Blood,2003

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients;Transplantation and Cellular Therapy;2024-07

2. AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML;Leukemia;2024-05-09

3. Measurable Residual Disease Assessment in Pediatric AML;Pediatric Oncology;2024

4. Stem Cell Transplantation and Cellular Immunotherapies for Pediatric AML;Pediatric Oncology;2024

5. Wilms Tumor: Updates about Pathogenesis and New Possible Clinical Treatments of the Most Frequent Pediatric Urogenital Cancer: A Narrative Review;Surgeries;2023-12-08